While I do agree with you about BIT225 being a good candidate as the next gen anti-viral - and I hope this will be an avenue that BIT engages in. The situation is that the trials have not been don on this application.
Information can b gleaned from the two trials BUT there would need to be a separate set of trials to test the anti-viral potential.
This is why trials are done in the first place.
$10 Billion Deal, page-13026
-
- There are more pages in this discussion • 242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.45M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 164 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 163 | 1 |
View Market Depth
| Last trade - 08.13am 15/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable